RxDoctor Payments Data

Dennis Ruppel, MD

Family Medicine · New Albany, OHNPI 1114966488

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $28,989 of the $38,493 with a category attached, or 75.3%. Pfizer accounts for 99.6% of it on its own, with 5 other manufacturers making up the rest. Among family medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,493in general payments, 2019–2025

Across 42 payments — averaging $916.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$38K
  • Abbott$50
  • Novo Nordisk$43
  • AbbVie$43
  • Dexcom, Inc.$21
  • Merck$13

What the payments were for

  • Consulting fees$7,40319%
  • Speaking & faculty fees$28,98975%
  • Travel & lodging$1,2923%
  • Food & beverage$8102%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer34$38,323
Abbott2$50
Novo Nordisk2$43
AbbVie2$43
Dexcom, Inc.1$21
Merck1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,493 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$30,050
Medicare patients
106
Services billed
293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban61$68,727
JanuviaSitagliptin Phosphate32$50,511
XareltoRivaroxaban27$37,376
OzempicSemaglutide15$32,107
JardianceEmpagliflozin22$31,318
Atorvastatin Calcium242$3,446
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,356
Tamsulosin Hcl78$2,004
Celecoxib33$1,770
Omeprazole119$1,387
Metoprolol Succinate57$1,252
Lisinopril183$1,244
Pantoprazole Sodium64$1,065
Finasteride61$1,024
Losartan Potassium78$1,008

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$38,323$68,72761 claims
MerckJanuvia$13$50,51132 claims
Novo NordiskOzempic$43$32,10715 claims
AbbVieSynthroid$43$51322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in New Albany

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →